DNLI
Price
$13.95
Change
+$0.52 (+3.87%)
Updated
Sep 26 closing price
Capitalization
2.04B
33 days until earnings call
RAPP
Price
$26.59
Change
+$1.62 (+6.49%)
Updated
Sep 26 closing price
Capitalization
1.23B
40 days until earnings call
Interact to see
Advertisement

DNLI vs RAPP

Header iconDNLI vs RAPP Comparison
Open Charts DNLI vs RAPPBanner chart's image
Denali Therapeutics
Price$13.95
Change+$0.52 (+3.87%)
Volume$2.33M
Capitalization2.04B
Rapport Therapeutics
Price$26.59
Change+$1.62 (+6.49%)
Volume$1.13M
Capitalization1.23B
DNLI vs RAPP Comparison Chart in %
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. RAPP commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Buy and RAPP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (DNLI: $13.95 vs. RAPP: $26.59)
Brand notoriety: DNLI and RAPP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 114% vs. RAPP: 133%
Market capitalization -- DNLI: $2.04B vs. RAPP: $1.23B
DNLI [@Biotechnology] is valued at $2.04B. RAPP’s [@Biotechnology] market capitalization is $1.23B. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileRAPP’s FA Score has 1 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • RAPP’s FA Score: 1 green, 4 red.
According to our system of comparison, RAPP is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 5 TA indicator(s) are bullish while RAPP’s TA Score has 5 bullish TA indicator(s).

  • DNLI’s TA Score: 5 bullish, 5 bearish.
  • RAPP’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RAPP is a better buy in the short-term than DNLI.

Price Growth

DNLI (@Biotechnology) experienced а +9.41% price change this week, while RAPP (@Biotechnology) price change was +0.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

DNLI is expected to report earnings on Oct 30, 2025.

RAPP is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.04B) has a higher market cap than RAPP($1.23B). RAPP YTD gains are higher at: 49.887 vs. DNLI (-31.551). RAPP has higher annual earnings (EBITDA): -100.79M vs. DNLI (-521.52M). DNLI has more cash in the bank: 899M vs. RAPP (260M). RAPP has less debt than DNLI: RAPP (11.9M) vs DNLI (46.6M). DNLI (0) and RAPP (0) have equivalent revenues.
DNLIRAPPDNLI / RAPP
Capitalization2.04B1.23B166%
EBITDA-521.52M-100.79M517%
Gain YTD-31.55149.887-63%
P/E RatioN/A22.16-
Revenue00-
Total Cash899M260M346%
Total Debt46.6M11.9M392%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
86
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIRAPP
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
87%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 20 days ago
77%
Bullish Trend 4 days ago
90%
Declines
ODDS (%)
Bearish Trend 13 days ago
81%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IEQAX17.260.16
+0.94%
ICON Equity Income Investor
TFIFX48.750.35
+0.72%
T. Rowe Price Financial Services I
PYODX47.020.29
+0.62%
Victory Pioneer Y
STCZX18.100.06
+0.33%
Virtus Silvant Large-Cap Growth Stk R6
CAHEX18.780.05
+0.27%
Calamos Hedged Equity A

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with NRIX. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
+3.87%
NRIX - DNLI
59%
Loosely correlated
+7.20%
OCUL - DNLI
54%
Loosely correlated
+2.37%
RGNX - DNLI
54%
Loosely correlated
+3.10%
BEAM - DNLI
54%
Loosely correlated
-0.52%
IMVT - DNLI
54%
Loosely correlated
+3.57%
More

RAPP and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPP has been loosely correlated with NEVPF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RAPP jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPP
1D Price
Change %
RAPP100%
+6.49%
NEVPF - RAPP
45%
Loosely correlated
N/A
FTRE - RAPP
35%
Loosely correlated
-2.69%
PRAX - RAPP
35%
Loosely correlated
+6.48%
MLTX - RAPP
35%
Loosely correlated
+9.95%
DNLI - RAPP
32%
Poorly correlated
+3.87%
More